Bridging the gap between Research and the Clinic

The development of breakthrough, effective and cost-efficient oncology drugs that can be translated into clinical settings stands-out as a major challenge in Oncology research.

Whether you are in the process of discovery or ready to move your product into the clinical development phase, VectorB2B expertise and state-of-the-art facilities can help you in every step of the way.

VectorB2B offers an integrated approach to oncology research and drug development. We offer a wide range of preclinical models for efficacy and safety screening of biologic and chemical drugs. We also have access to a range of human tumor samples which can be used for biomarker studies or PDX models.

We offer a low risk “one stop shop” for large- or small-scale projects, made possible by the depth of experience and expertise of VectorB2B scientific team. VectorB2B will deliver high quality custom or standard drug discovery solutions on time and on budget.

How can we support your oncology R&D?